Nasal Antisepsis for C. Auris Prevention
Nasal Antisepsis for C. Auris Prevention
Recruiting · NCT06282510 · Registry updated 2025-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nasal Antisepsis for C. Auris Prevention | Asymptomatic Colonization, Asymptomatic Diseases, Asymptomatic Infections, Candida auris infection, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 4 | 2025-10-15 | NCT06282510 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mary K Hayden | 1 |
| RML Specialty Hospital | 1 |
| Rush University Medical Center | 106 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| RML Specialty Hospital | Chicago | United States | 1 |
| RML Specialty Hospital | Hinsdale | United States | 2 |
| Rush University Medical Center | Chicago | United States | 283 |